文献速递银屑病与炎症性皮肤病

精神分裂症患者银屑病发病风险:全国性回顾性队列研究

Risk of developing psoriasis in patients with schizophrenia: a nationwide retrospective cohort study.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2017-06-09

该研究基于台湾全民健康保险研究数据库百万人群队列,分析1996至2010年确诊精神分裂症患者与未确诊者的银屑病风险。结果显示精神分裂症患者银屑病调整风险比为2.32(95%CI=1.81-2.98),15年累积发病率2.82%对1.17%,差异显著。提示两种疾病可能存在共同遗传易感性或免疫机制。

要点

  • 精神分裂症患者银屑病风险显著升高,调整HR为2.32。
  • 15年累积发病率精神分裂症组2.82%,对照组1.17%。
  • Th17信号通路可能是两种疾病关联的免疫机制。

核心结论

  • 精神分裂症患者发生银屑病的风险显著高于无精神分裂症人群。

研究设计与样本

  • 全国性回顾性队列研究,分析台湾全民健康保险研究数据库百万人群队列。
  • 采用Cox比例风险回归计算风险比及95%置信区间。

主要发现

  • 精神分裂症与银屑病相关的调整风险比为2.32(95%CI=1.81-2.98)。
  • 15年后精神分裂症患者银屑病累积发病率为2.82%,对照人群为1.17%。
  • Kaplan-Meier曲线显示两组银屑病累积发病率差异显著(P < 0.0001,log-rank检验)。

临床怎么用

  • 皮肤科医生接诊精神分裂症患者时应警惕银屑病可能,必要时进行皮肤专科评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Schizophrenia is a complex disease which proceeds from an interaction between genetic background and environmental factors. Recent studies showed T helper 17 (Th17) signalling, which is the main downstream immune response of psoriasis, is activated in schizophrenia. OBJECTIVE: To investigate whether patients with schizophrenia have higher risk of psoriasis. METHODS: In this nationwide retrospective cohort study, we analysed the 1 million enrollees' cohort from Taiwan's National Health Insurance Research Database. Psoriasis and schizophrenia were ascertained by International Classification of Diseases, 9th revision, Clinical Modification coding. The study cohort was comprised of enrollees diagnosed with schizophrenia during the period from 1 January 1996 through 31 December 2010, while the comparison population consisted of enrollees who had not been diagnosed with schizophrenia during the study period. Hazard ratio (HR) and 95% confidence interval (CI) were calculated for the risk of psoriasis associated with schizophrenia using Cox proportional hazard regression. RESULTS: The adjusted HR of psoriasis associated with schizophrenia was 2.32 (95% CI = 1.81-2.98). After 15 years, the cumulative incidence of psoriasis in patients with schizophrenia and comparison population was 2.82% and 1.17%, respectively. The Kaplan-Meier curves for the cumulative incidence of psoriasis in individuals with and without schizophrenia differed significantly (P < 0.0001, log-rank test). CONCLUSIONS: Patients with schizophrenia have higher risk of psoriasis, which may be due to common genetic susceptibilities and/or immunologic mechanisms in both diseases. Th17 signalling and pro-inflammatory cytokines may act as a link between these two diseases and are potential therapeutic targets for schizophrenia.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Yu S, Yu CL, Huang YC, et al. Risk of developing psoriasis in patients with schizophrenia: a nationwide retrospective cohort study. J Eur Acad Dermatol Venereol. 2017. PMID: 28467611. doi:10.1111/jdv.14303

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。